187 related articles for article (PubMed ID: 36607480)
1. Delivery of curcumin within emulsome nanoparticles enhances the anti-cancer activity in androgen-dependent prostate cancer cell.
Bolat ZB; Islek Z; Sahin F; Ucisik MH
Mol Biol Rep; 2023 Mar; 50(3):2531-2543. PubMed ID: 36607480
[TBL] [Abstract][Full Text] [Related]
2. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin.
Ucisik MH; Küpcü S; Schuster B; Sleytr UB
J Nanobiotechnology; 2013 Dec; 11():37. PubMed ID: 24314310
[TBL] [Abstract][Full Text] [Related]
3. Curcumin- and Piperine-Loaded Emulsomes as Combinational Treatment Approach Enhance the Anticancer Activity of Curcumin on HCT116 Colorectal Cancer Model.
Bolat ZB; Islek Z; Demir BN; Yilmaz EN; Sahin F; Ucisik MH
Front Bioeng Biotechnol; 2020; 8():50. PubMed ID: 32117930
[TBL] [Abstract][Full Text] [Related]
4. Modulation of AKR1C2 by curcumin decreases testosterone production in prostate cancer.
Ide H; Lu Y; Noguchi T; Muto S; Okada H; Kawato S; Horie S
Cancer Sci; 2018 Apr; 109(4):1230-1238. PubMed ID: 29369461
[TBL] [Abstract][Full Text] [Related]
5. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
6. Anti-cancer activity of curcumin loaded nanoparticles in prostate cancer.
Yallapu MM; Khan S; Maher DM; Ebeling MC; Sundram V; Chauhan N; Ganju A; Balakrishna S; Gupta BK; Zafar N; Jaggi M; Chauhan SC
Biomaterials; 2014 Oct; 35(30):8635-48. PubMed ID: 25028336
[TBL] [Abstract][Full Text] [Related]
7. Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.
Guo H; Xu YM; Ye ZQ; Yu JH; Hu XY
Pharmazie; 2013 Jun; 68(6):431-4. PubMed ID: 23875250
[TBL] [Abstract][Full Text] [Related]
8. Human prostate cancer cell epithelial-to-mesenchymal transition as a novel target of arsenic trioxide and curcumin therapeutic approach.
Mirzaei A; Jahanshahi F; Khatami F; Reis LO; Aghamir SMK
Tissue Cell; 2022 Jun; 76():101805. PubMed ID: 35487055
[TBL] [Abstract][Full Text] [Related]
9. Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor - Synergistic action of quercetin and curcumin.
Sharma V; Kumar L; Mohanty SK; Maikhuri JP; Rajender S; Gupta G
Mol Cell Endocrinol; 2016 Aug; 431():12-23. PubMed ID: 27132804
[TBL] [Abstract][Full Text] [Related]
10. [Curcumin-induced apoptosis in androgen-dependent prostate cancer cell line LNCaP in vitro].
Guo H; Yu JH; Chen K; Ye ZQ; Liu GC
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):141-4. PubMed ID: 16519151
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells.
Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M
Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105
[TBL] [Abstract][Full Text] [Related]
12. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells.
Katta S; Srivastava A; Thangapazham RL; Rosner IL; Cullen J; Li H; Sharad S
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581661
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.
Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T
Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968
[TBL] [Abstract][Full Text] [Related]
15. Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation.
Zhou DY; Ding N; Du ZY; Cui XX; Wang H; Wei XC; Conney AH; Zhang K; Zheng X
Mol Med Rep; 2014 Sep; 10(3):1315-22. PubMed ID: 25060817
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor.
Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S
J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617
[TBL] [Abstract][Full Text] [Related]
17. [Curcumin-induced the expression of inhibitor kappaBalpha protein in human prostate cancer cells].
Guo H; Yu JH; Chen K; Ye ZQ
Zhonghua Wai Ke Za Zhi; 2006 Sep; 44(18):1256-9. PubMed ID: 17147887
[TBL] [Abstract][Full Text] [Related]
18. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1).
Srivastava RK; Chen Q; Siddiqui I; Sarva K; Shankar S
Cell Cycle; 2007 Dec; 6(23):2953-61. PubMed ID: 18156803
[TBL] [Abstract][Full Text] [Related]
19. Curcumin downregulates homeobox gene NKX3.1 in prostate cancer cell LNCaP.
Zhang HN; Yu CX; Zhang PJ; Chen WW; Jiang AL; Kong F; Deng JT; Zhang JY; Young CY
Acta Pharmacol Sin; 2007 Mar; 28(3):423-30. PubMed ID: 17303007
[TBL] [Abstract][Full Text] [Related]
20. Antitumor mechanism of combination of Angelica gigas and Torilis japonica in LNCaP prostate cancer cells via G1 arrest and inhibition of Wnt/β-catenin and androgen receptor signaling.
Kim DH; Im E; Lee DY; Lee HJ; Sim DY; Park JE; Ahn CH; Koo JI; Pak JN; Kim SH
Phytother Res; 2022 Jul; 36(7):2999-3008. PubMed ID: 35634973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
